© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
Expression profiling of human idiopathic dilated cardiomyopathy
aMax-Planck Institute for Molecular Genetics, Ihnestr. 73, 14195 Berlin, Germany
bAnadys Pharmaceuticals Europe GmbH, Meyerhofstr. 1, 69117 Heidelberg, Germany
cUniversitätsklinikum Charité/Kardiologie, Campus Buch & Virchow-Klinikum, Humboldt-Universität zu Berlin, Wiltbergstrasse 50, 13125 Berlin, Germany
* Corresponding author. Tel.: +49-30-8413-1682; fax: +49-30-8413-1365. ruiz{at}molgen.mpg.de
Objective: To investigate the global changes accompanying human dilated cardiomyopathy (DCM) we performed a large-scale expression screen using myocardial biopsies from a group of DCM patients with moderate heart failure. By hierarchical clustering and functional annotation of the deregulated genes we examined extensive changes in the cellular and molecular processes associated to DCM. Methods: The expression profiles were obtained using a whole genome covering library (UniGene RZPD1) comprising 30 336 cDNA clones and amplified RNA from myocardiac biopsies from 10 DCM patients in comparison to tissue samples from four non-failing, healthy donors. Results: By setting stringent selection criteria 364 differentially expressed, sequence-verified non-redundant transcripts were identified with a false discovery rate of <0.001. Numerous genes and ESTs were identified representing previously recognised, as well as novel DCM-associated transcripts. Many of them were found to be upregulated and involved in cardiomyocyte energetics, muscle contraction or signalling. Two hundred and twenty-two deregulated transcripts were functionally annotated and hierarchically clustered providing an insight into the pathophysiology of DCM. Data was validated using the MLP-deficient mouse, in which several differentially expressed transcripts identified in the human DCM biopsies could be confirmed. Conclusions: We report the first genome-wide expression profile analysis using cardiac biopsies from DCM patients at various stages of the disease. Although there is a diversity of links between the cytoskeleton and the initiation of DCM, we speculate that genes implicated in intracellular signalling and in muscle contraction are associated with early stages of the disease. Altogether this study represents the most comprehensive and inclusive molecular portrait of human cardiomyopathy to date.
KEYWORDS UniGene; Cardiomyopathy; Cardiac biopsy; Expression profile; cDNA array
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. V. Naga Prasad, Z.-H. Duan, M. K. Gupta, V. S. K. Surampudi, S. Volinia, G. A. Calin, C.-G. Liu, A. Kotwal, C. S. Moravec, R. C. Starling, et al. Unique MicroRNA Profile in End-stage Heart Failure Indicates Alterations in Specific Cardiovascular Signaling Networks J. Biol. Chem., October 2, 2009; 284(40): 27487 - 27499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Muchir, J. Shan, G. Bonne, S. E. Lehnart, and H. J. Worman Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins Hum. Mol. Genet., January 15, 2009; 18(2): 241 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Ruppert, T. Meyer, S. Pankuweit, E. Moller, R. C. Funck, W. Grimm, B. Maisch, and German Heart Failure Network Gene expression profiling from endomyocardial biopsy tissue allows distinction between subentities of dilated cardiomyopathy. J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 360 - 369.e1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Samuel, M. C. Schaub, M. Zaugg, M. Mamas, W. B. Dunn, and B. Swynghedauw Genomics in cardiac metabolism Cardiovasc Res, July 15, 2008; 79(2): 218 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Haddad, L. J. Saunders, S. D. Crosby, M. Carles, F. del Monte, K. King, M. R. Bristow, F. G. Spinale, T. E. Macgillivray, M. J. Semigran, et al. Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences Physiol Genomics, April 1, 2008; 33(2): 267 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ojaimi, K. Qanud, T. H. Hintze, and F. A. Recchia Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs Physiol Genomics, March 14, 2007; 29(1): 76 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-C. Lin, K. Gyenai, R. L. Pyle, T. Geng, J. Xu, and E. J. Smith Candidate Gene Expression Analysis of Toxin-Induced Dilated Cardiomyopathy in the Turkey (Meleagris gallopavo) Poult. Sci., December 1, 2006; 85(12): 2216 - 2221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Donahue, D. A. Marchuk, and H. A. Rockman Redefining Heart Failure: The Utility of Genomics J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1289 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. van Oort, E. van Rooij, M. Bourajjaj, J. Schimmel, M. A. Jansen, R. van der Nagel, P. A. Doevendans, M. D. Schneider, C. J.A. van Echteld, and L. J. De Windt MEF2 Activates a Genetic Program Promoting Chamber Dilation and Contractile Dysfunction in Calcineurin-Induced Heart Failure Circulation, July 25, 2006; 114(4): 298 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Beisvag, P. K. Lehre, H. Midelfart, H. Aass, O. Geiran, A. K. Sandvik, A. Laegreid, J. Komorowski, and O. Ellingsen Aetiology-specific patterns in end-stage heart failure patients identified by functional annotation and classification of microarray data Eur J Heart Fail, June 1, 2006; 8(4): 381 - 389. [Abstract] [Full Text] [PDF]
|
|